Advancing Digital Health Solutions
Hilo by Aktiia, a pioneering force in the Swiss healthtech sector, has announced a significant financial milestone. The company successfully secured a total of $119 million in funding, highlighted by a recent $19 million Series B extension. This investment round was notably backed by the Dell Family Office, signaling strong institutional confidence in the firm’s proprietary wearable technology.
Expanding Global Healthcare Reach
The capital injection will enable Hilo by Aktiia to accelerate the development of its non-invasive blood pressure monitoring solutions. By integrating artificial intelligence with clinical-grade sensors, the company aims to provide real-time cardiovascular insights for patients across the United Kingdom and international markets. The Dailyza team notes that this funding underscores the rising demand for remote patient monitoring tools that bridge the gap between clinical settings and daily life.
Strategic Growth and Innovation
With this latest influx of capital, Hilo by Aktiia plans to scale its research and development operations. The company is focused on enhancing its data analytics platform to improve long-term health outcomes for individuals suffering from hypertension. As the healthtech landscape continues to evolve, the firm remains committed to delivering medically validated insights that empower users to manage their health proactively. This investment positions the company as a leader in the competitive digital health market, providing a robust foundation for future expansion and product diversification.